Five notes:
1. For the fourth quarter, the company expects sales to be approximately $195.5 million, an 11 percent increase year over year.
2. Globus Medical expects full-year sales to be approximately $712.5 million, a 12 percent hike year over year.
3. The company’s emerging technologies segment is predicted to have generated $14.8 million in the fourth quarter, a 35 percent increase year over year.
4. Within its U.S. spinal implant business, Globus Medical estimates a 9 percent increase year over year.
5. In 2019, Globus Medical predicts year-end sales will be approximately $770 million.
More articles on devices and implants:
Barclays analyst criticizes Medtronic — Here’s what CEO Omar Ishrak had to say
Medtronic issues Class 1 recall of cranial software: 5 things to know
Integra LifeSciences develops short stem, stemless shoulder system: 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.